Losartan was renoprotective in diabetic nephropathy independent of its effect on blood pressure

May 2002
ACP Journal Club;May/Jun2002, Vol. 136 Issue 3, p84
Academic Journal
Presents information on a study which examined the effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. Outcome measures; Results; Conclusions.


Related Articles

  • Stemming proteinuria in insulin-dependent diabetes. Viberti, G.; Mogensen, C.E. // Patient Care;4/30/1994, Vol. 28 Issue 8, p76 

    Reports that angiotensin-converting-enzyme inhibitors may slow the progression of diabetes-associated proteinuria and diabetic nephropathy. Albumin excretion rate; Drop in mean arterial blood pressure; Effects of captopril in renal function.

  • Nutrient Sensing, Autophagy, and Diabetic Nephropathy. Kume, Shinji; Thomas, Merlin C.; Koya, Daisuke // Diabetes;Jan2012, Vol. 61 Issue 1, p23 

    The article explains the possible use of nutrient-sensing pathways as a therapeutic target for diabetic nephropathy. It explains the physiological mechanisms of nutrient sensing, the process of autophagy, and diabetic nephropathy. Particular focus is given to the role of mammalian target of...

  • Effects of aminoguanidine and vitamin C on collagen type IV in diabetic nephropathy rats. Qiangxiang Li; Xiang Ao; Youhong Du; Yang Li; Yangshi Ou; Raofeng Gong; Xuexiong Sun; Yi Xiang Yang; Gebo Wen // Endocrine (1355008X);Jun2011, Vol. 39 Issue 3, p251 

    The aim of this article is to investigate the effects of Aminoguanidine and vitamin C (VitC) on type IV collagen in diabetic nephropathy rats. Diabetic nephropathy rats were induced by intraperitoneal injection of STZ. Rats were randomly divided into five groups: normal control group ( n = 10),...

  • Assess diabetes complications and therapies pre-pregnancy.  // New Zealand Doctor;8/5/2015, p34 

    The article focuses on the need to assess diabetes complications prior to pregnancy, such as diabetic retinopathy, diabetic nephropathy and ischaemic heart disease. Topics discussed include the use of angiotensin-converting enzyme (ACE) inhibitors to treat women with diabetic nephropathy and...

  • CAPTOPRIL MAY PRESERVE KIDNEY FUNCTION IN DIABETICS. Hurley, Mary Lou // RN;Mar94, Vol. 57 Issue 3, p72 

    Reports on the study which indicates that the ACE inhibitor captopril or Capoten protects against the loss of renal function in patients with diabetic nephropathy. Publication of the study by E.J. Lewis, L.G. Hunsicker and others in the 1993 issue of the `New England Journal of Medicine';...

  • A Review of Oxidative Stress Related Genes and New Antioxidant Therapy in Diabetic Nephropathy. Makuc, Jana; Petrovic, Danijel // Cardiovascular & Hematological Agents in Medicinal Chemistry;2011, Vol. 9 Issue 4, p253 

    A genetic component of diabetes and its complications (including diabetic nephropathy (DN)) is obvious, but the causative genes and mechanisms have not yet been satisfactorily identified. Oxidative stress is a single mechanism relating all major pathways responsible for diabetic damage. Numerous...

  • More about Kidney Nephropathy.  // Podiatry Review;Sep/Oct2013, Vol. 70 Issue 5, p25 

    The article provides information on kidney diseases, which is common in people with diabetes and people with high blood pressure. The kidneys are the organs that filter and clean the blood and get rid of any waste products by making urine, and as with many of the other complications of diabetes,...

  • Cholesterol Accumulation in Podocytes: A Potential Novel Targetable Pathway in Diabetic Nephropathy. Tufro, Alda // Diabetes;Nov2013, Vol. 62 Issue 11, p3661 

    The author discusses a study by S. Merscher-Gomez and colleagues on the pathogenic role of cholesterol accumulation in podocytes in diabetic nephropathy. He highlights topics on the effect of diabetic nephropathy on the development of end-stage renal disease, abnormalities in lipid metabolism...

  • Targeting the MCP-1/CCR2 System in Diabetic Kidney Disease. Giunti, Sara; Barutta, Federica; Perin, Paolo Cavallo; Gruden, Gabriella // Current Vascular Pharmacology;Nov2010, Vol. 8 Issue 6, p849 

    No abstract available.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics